Suchergebnisse - "Graft vs. Host disease"

PubPharm (1.630)

1

CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease : CXC-chemokine Ligand 9 (CXCL9) and Endothelial Activation and Stress Index (EASIX) for Prediction of Acute Graft Versus Host Disease

enthalten in: ClinicalTrials.gov | 2024

2

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives : Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections From Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation

enthalten in: ClinicalTrials.gov | 2024

3

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants : Long-Term Evaluation and Follow Up Care of Patients Treated With Allogeneic Stem Cell Transplants

enthalten in: ClinicalTrials.gov | 2024

4

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant : Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)

enthalten in: ClinicalTrials.gov | 2024

5

Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab

enthalten in: Transplantation and cellular therapy | 2024

von Kennedy, V. | Sahaf, B. | Wu, F. | +3

6

Cellular senescence promotes meibomian gland dysfunction in a chronic graft-versus-host disease mouse model

enthalten in: The ocular surface | 2024

von Sato, S. | Ogawa, Y. | Shimizu, E. | +7

7

Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients : Dry Eye and Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients

enthalten in: ClinicalTrials.gov | 2024

8

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation : A Randomized Phase 2 Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation

enthalten in: ClinicalTrials.gov | 2024

9

RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation : An Open Label Phase 2, Study to Evaluate the Safety and Efficacy of RGI-2001 for the Prevention of Acute Graft-vs-Host Disease Compared to Contemporary Controls in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

enthalten in: ClinicalTrials.gov | 2024

10

Pediatric cGVHD Symptom Scale : Development and Psychometric Testing of a Pediatric Chronic Graft- Versus-Host Disease (GVHD) Symptom Scale (PCSS)

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[163]